Wound Debridement Market Report

Wound Debridement Market Analysis Report By Product (Gels, Ointments & Creams), By Method, By Wound Type (Diabetic Foot, Pressure Ulcers), By End Use, And Segment Forecasts, 2018 - 2025

  • Published Date: Oct, 2018
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-462-8
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 120

Industry Insights

The global wound debridement market size was valued at USD 4.34 billion in 2017. It is likely to register a CAGR of 6.10% during the forecast period. Growing number of accidents and fire outbreaks are leading to rise in the cases of injuries. This, in turn, is stoking the growth of the market. Besides this, increase in wounds induced by diabetes, due to rising incidence of the condition, is providing an upthrust to the market.

In addition, spiraling adoption of debridement products and techniques to heal a wound faster is propelling the market. Presence of micro-organisms and toxins on the wound inhibits healing and may lead to infection. Debridement removes the dead or infected tissues from the wound in order to promote healing. Increasing initiatives by government and private organizations to raise awareness regarding wound care treatment is projected to work in favor of the market.

North America wound debridement market

Rising incidence of ulcers is anticipated to further boost the growth of the market. As per statistics by the American Diabetes Association, in 2014, about 2.0% of the population of the U.S. was affected with diabetic ulcer. Similarly, about 600,000 people are affected by venous ulcer in the country every year. 

Moreover, improving healthcare facilities in several parts of the world and introduction of reimbursement policies are poised to stimulate the growth of the market. Apart from this, advent of advanced wound care products and their increased adoption are positively influencing the growth of the market. Widening base of geriatric population is also estimated to contribute to the growth of the market.

Product Insights

Based on products, the market has been segmented into gel, ointment & creams, ultrasonic devices, surgical devices, medical gauzes, and other debridement products. Gel accounted for the largest share in 2017 due to its benefits such as no inflammation, less bleeding, and removal of necrotic tissues safely, without causing infection.

Ultrasonic devices have been estimated to be the fastest growing segment owing to its ability to kill micro-organisms at wound site without damaging blood vessels. The ultrasonic device also differentiates non-viable tissues and viable tissues and removes only non-viable tissues without affecting healthy ones.

Method Insights

The market, on the basis of method, has been segmented into autolysis, enzymatic, mechanical, surgical, and others. Surgical debridement represented the largest share in the market as this procedure is rapid and is applicable to many types of wounds. Mechanical debridement is the most common procedure due to increasing incidence of minor injuries and surging demand for cost efficient treatment.

On the other hand, autolytic debridement has been expected to be the fastest growing segment due to its self-healing properties, wherein body’s own moisture and enzymes help in recovery of the wound. However, autolytic debridement is limited to wounds that are not infected or with lesser amount of dead tissues. Autolytic debridement can be enhanced using hydrogels, hydrocolloids, and transparent films.

End-use Insights

By end-use, the wound debridement market is divided into hospitals, home care, and others. Hospital was the most prominent segment in the market in 2017. Increasing surgical procedures and growing incidence of chronic wounds are likely to support the dominance of the segment throughout the forecast period. In addition, presence of skilled professionals and improving infrastructure in developing economies are also boosting the growth of the segment.

Homecare is anticipated to be the most promising segment during the forecast period. Most of the surgeries involve an extended healing time, which may require frequent changing of dressings. This factor is projected to supplement the growth of the market. Wound debridement in homecare settings has evolved with introduction of single-use NPWT systems. This is primarily due to their lightweight, portability, and canister-free feature.

Wound Type Insights

In terms of wound type, the market has been categorized into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and burn injuries. Diabetic foot ulcers are observed as the fastest growing segment due to increasing prevalence of diabetes. About 15.0% of diabetic foot ulcers result in amputation, therefore, need to heal the wound in its nascent stage is necessary.

Pressure ulcers, on the other hand, held the largest share in the market in 2017 owing to increasing incidence of bedsores. In addition, skin of aged people is highly sensitive and is more prone towards developing bedsores, thereby bolstering the growth of the segment.

Regional Insights

North America was the leading revenue contributor in the global arena in 2017, with a share of approximately 40.0%. The growth of the region can be attributed to presence of developed medical infrastructure and increasing patient awareness coupled with rising disposable income and soaring need for quality medical products and services.

Global wound debridement market

Asia Pacific is poised to witness lucrative growth during the forecast period. Booming economies, reforms to improve infrastructure, high unmet needs of huge population, and availability skilled labor are triggering the growth of the regional market. Europe is also estimated to hold a sizeable share in the market during the same period.

Wound Debridement Market Share Insights

Some of the prominent companies operating in the market are Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mölnlycke Health Care; Lohmann & Rauscher; Medline Industries; and Integra Lifesciences.

These players, in order to gain a higher market share, are involved in various strategic initiatives such as collaborations, regional expansion, service portfolio expansion, mergers, and acquisitions. For instance, in June 2018, Acelity L.P. Inc. acquired Crawford Healthcare to expand its advanced wound dressing portfolio and thereby, strengthening its position as the global leader in advanced wound care.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2016

Forecast period

2018 - 2025

Market representation

Revenue in USD Million & CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, U.K., Germany, Japan, China, Brazil, Mexico, South Africa, Saudi Arabia

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research, Inc. has segmented the global wound debridement market report on the basis of product, method, wound type, end use, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Gels

    • Ointment & Creams

    • Surgical Devices

    • Medical Gauze & pads

    • Ultrasonic Devices

    • Others

  • Method Outlook (Revenue, USD Million, 2014 - 2025)

    • Autolytic

    • Enzymatic

    • Surgical

    • Mechanical

    • Others

  • Wound Type Outlook (Revenue, USD Million, 2014 - 2025)

    • Pressure ulcer

    • Diabetic foot ulcer

    • Venous leg ulcer

    • Burn wounds

    • Others

  • End-use Outlook (Revenue, USD Million, 2014 - 2025)

    • Hospital

    • Homecare

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified